Genenta Science S.p.A. (SAEN) stock

SAENNasdaqBiological Products, (No Diagnostic Substances)Also trades as GNTA

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30

$0.68−0.04 (-5.28%)

Close on Nov 11, 2026Market cap $15.93MP/E –Yield –

Genenta Science S.p.A. ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -€6.58M. The highest annual figure on record is -€5.59M in fiscal 2020.

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-€6.58M	–
FY2024	Dec 31, 2024	-€9.72M	–
FY2023	Dec 31, 2023	-€11.69M	–
FY2022	Dec 31, 2022	-€11.04M	–
FY2021	Dec 31, 2021	-€5.68M	–
FY2020	Dec 31, 2020	-€5.59M	–

See a number that looks wrong?